Mabwell(SH:688062) Zhong Guo Ji Jin Bao·2025-09-01 05:22Market Overview - On September 1, the A-share market experienced fluctuations, with the Shanghai Composite Index rising by 0.12%, the Shenzhen Component Index by 0.11%, and the ChiNext Index by 0.55% [1][2] - The total trading volume for the market reached 1.85 trillion yuan, slightly lower than the previous day, with over 3,100 stocks rising [2] Precious Metals Sector - The precious metals sector saw significant gains, with gold, jewelry, cobalt, and small metal stocks becoming active [5][6] - Notable stocks that hit the daily limit included Haixing Co., Jintong Co., Shengda Resources, and Western Gold, among others [6] - The rise in precious metals was attributed to increased attractiveness due to expectations of a Federal Reserve rate cut, alongside geopolitical risks and trade tensions [7][8] Innovative Pharmaceuticals Sector - The innovative pharmaceutical sector was notably active, with stocks like Maiwei Biotech hitting the daily limit, alongside others such as Baihua Pharmaceutical and First Pharmaceutical [8][9] - Maiwei Biotech announced the approval of its two monoclonal antibody injection products in Pakistan, marking its first overseas registration [13] - The company also entered into a licensing agreement with CALICO LIFESCIENCES LLC, receiving an upfront payment of $25 million and potential milestone payments totaling up to $571 million [13] Stock Performance Highlights - Maiwei Biotech's stock price increased by 20% to 57.60 yuan, with a trading volume of 24.39 million shares [10][11] - Other notable performers in the pharmaceutical sector included Baijia Shenzhou and WuXi AppTec, both seeing significant gains [14]